329 related articles for article (PubMed ID: 26740749)
1. Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance.
Makki J
Clin Med Insights Pathol; 2015; 8():23-31. PubMed ID: 26740749
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of tumours of ductal and lobular origin: I. Proteomics of invasive ductal and lobular breast carcinomas.
Turashvili G; Bouchal J; Burkadze G; Kolár Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):57-62. PubMed ID: 16170389
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.
Oliveira NC; Gomig TH; Milioli HH; Cordeiro F; Costa GG; Urban CA; Lima RS; Cavalli IJ; Ribeiro EM
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173185
[TBL] [Abstract][Full Text] [Related]
4. Expression of calretinin in high-grade hormone receptor-negative invasive breast carcinomas: correlation with histological and molecular subtypes.
Micello D; Bossi A; Marando A; Dainese E; Sessa F; Capella C
Virchows Arch; 2017 Jul; 471(1):13-21. PubMed ID: 28550498
[TBL] [Abstract][Full Text] [Related]
5. Analysis of a new histological and molecular-based classification of canine mammary neoplasia.
Im KS; Kim NH; Lim HY; Kim HW; Shin JI; Sur JH
Vet Pathol; 2014 May; 51(3):549-59. PubMed ID: 24003019
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtypes of breast carcinoma in Egyptian women: clinicopathological features.
El-Hawary AK; Abbas AS; Elsayed AA; Zalata KR
Pathol Res Pract; 2012 Jul; 208(7):382-6. PubMed ID: 22641056
[TBL] [Abstract][Full Text] [Related]
7. [Breast carcinoma in the man. Current results from the viewpoint of clinic and pathology].
Prechtel K; Prechtel V
Pathologe; 1997 Jan; 18(1):45-52. PubMed ID: 9157404
[TBL] [Abstract][Full Text] [Related]
8. The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer.
Liao HY; Zhang WW; Sun JY; Li FY; He ZY; Wu SG
J Cancer; 2018; 9(2):296-303. PubMed ID: 29344276
[No Abstract] [Full Text] [Related]
9. Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas.
Turashvili G; Bouchal J; Ehrmann J; Fridman E; Skarda J; Kolar Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):59-64. PubMed ID: 17690741
[TBL] [Abstract][Full Text] [Related]
10. Mammary cancer in the dog: a study of 120 cases.
Mulligan RM
Am J Vet Res; 1975 Sep; 36(9):1391-6. PubMed ID: 169716
[TBL] [Abstract][Full Text] [Related]
11. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy.
Crisi GM; Mandavilli S; Cronin E; Ricci A
Am J Surg Pathol; 2003 Mar; 27(3):325-33. PubMed ID: 12604888
[TBL] [Abstract][Full Text] [Related]
12. [Her-2 amplification and p185 expression in invasive breast cancer cells in women].
Titi S
Ann Acad Med Stetin; 2006; 52(2):5-12. PubMed ID: 17633393
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression Analysis Identifies Common and Distinct Signatures Underlying Ductal and Lobular Breast Cancers.
Huang Q; Liu J; Chen T; Li L; Wang L; Wu Y
J Reprod Med; 2017; 62(5-6):271-83. PubMed ID: 30027719
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
15. Invasive lobular carcinoma of the breast with extracellular mucin: A case report.
Gómez Macías GS; Pérez Saucedo JE; Cardona Huerta S; Garza Montemayor M; Villarreal Garza C; García Hernández I
Int J Surg Case Rep; 2016; 25():33-6. PubMed ID: 27315432
[TBL] [Abstract][Full Text] [Related]
16. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.
Oyama T; Kashiwabara K; Yoshimoto K; Arnold A; Koerner F
Cancer Res; 1998 Jul; 58(13):2876-80. PubMed ID: 9661905
[TBL] [Abstract][Full Text] [Related]
17. Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies.
Shimizu S; Kitamura H; Ito T; Nakamura T; Fujisawa J; Matsukawa H
Pathol Int; 1998 Jul; 48(7):549-56. PubMed ID: 9701019
[TBL] [Abstract][Full Text] [Related]
18. Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas.
de Oliveira MM; de Oliveira SF; Lima RS; de Andrade Urban C; Cavalli LR; de Souza Fonseca Ribeiro EM; Cavalli IJ
Hum Pathol; 2012 Oct; 43(10):1661-7. PubMed ID: 22503535
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of molecular subtypes of invasive breast cancer: A retrospective study.
Kumar N; Patni P; Agarwal A; Khan MA; Parashar N
Med J Armed Forces India; 2015 Jul; 71(3):254-8. PubMed ID: 26288493
[TBL] [Abstract][Full Text] [Related]
20. Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy.
Luveta J; Parks RM; Heery DM; Cheung KL; Johnston SJ
Oncol Ther; 2020 Jun; 8(1):1-11. PubMed ID: 32700069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
